Gadolinium Toxicity

Home » Posts tagged 'MRI Patient Safety'

Tag Archives: MRI Patient Safety

Breaking News

breakingnews

 

July 21, 2017 – European Medical Authority takes action on Linear Contrast Agents.  Read all about it.

March 10, 2017 – European group recommends to stop using 4 linear GBCAs Read all about it.

February 27, 2017 – New Study Reports Gadolinium Retention in 70 Cases with Normal Kidney Function. Read all about it.

Viewpoint Categories

We have an important advocate in Dr. Manny Kanal.

After years of trying to get the FDA and medical community’s attention about the issue of Gadolinium retention in patients with normal kidney function, it looks like our efforts have begun to pay off.

I want to share some news about Dr. Emanuel (Manny) Kanal.  If you aren’t familiar with his name, Dr. Kanal is a leading radiologist and someone the FDA looks to for advice on matters related to MRI Safety.  Duke and I have been in communication with him since October of 2013.

As you might imagine, MRI Safety is an important issue that requires medical professionals to stay well-informed about safety issues directly related to MR devices as well as the Gadolinium-based Contrast Agents administered for contrast-enhanced MRI and MRA.  Since June of this year, Dr. Kanal has been conducting MRI Safety Officer (MRSO) and MRI Medical Director (MRMD) Seminars.

During a seminar on September 9, 2014, Dr. Kanal provided a “Gadolinium Contrast Overview”.  According to the MRI Patient Safety blog, besides describing the state of NSF, he described “new and growing concerns about non-NSF bio-retention”.  (more…)

%d bloggers like this: